MSLE
Satellos Bioscience Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$122.90M
P/E Ratio
—
EPS
$-1.79
Beta
1.17
52W High
$13.39
52W Low
$4.52
50-Day MA
$7.01
200-Day MA
$7.36
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Satellos Bioscience Inc. Common Stock
Satellos Bioscience Inc., a biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia. The company is headquartered in Toronto, Canada.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $-4.28M |
| EBITDA | $-30.02M |
| Operating Margin | 0.00% |
| Return on Equity | -50.70% |
| Return on Assets | -31.40% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $3.39 |
| Price-to-Book | 1.74 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 4.75 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $20.83M |
| Float | $17.66M |
| % Insiders | 6.49% |
| % Institutions | 50.63% |
Historical Volatility
HV 10-Day
95.25%
HV 20-Day
82.21%
HV 30-Day
78.88%
HV 60-Day
96.08%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($27.67 target)
4
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026